article thumbnail

Indoco receives EIR for its manufacturing facility in Goa (Plant I)

Express Pharma

Indoco Remedies announced the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for their facility for solid dosages (Plant I) located in Verna, Goa.

Dosage 92
article thumbnail

BridgeBio’s drug for ATTR-CM gains US FDA approval

Express Pharma

Pfizer’s tafamidis capsules, sold as Vyndaqel and Vyndamax, were approved in 2019 and brought in sales of $3.32 Pfizer’s lower-dose version of tafamidis, sold under the brand Vyndamax, has a recommended dosage of 61 milligrams taken once daily as a single capsule. billion in 2023.

Dosage 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Transpire Bio signs with Recipharm for inhaled medicine development

European Pharmaceutical Review

According to the World Health Organization (WHO), asthma affected approximately 262 million people in 2019 and accounted for approximately 455,000 deaths. COPD was the third-leading cause of death in 2019, with approximately 3.2 We are very excited to be working with Recipharm to advance these important medicines.”. million lives lost.

Dosage 105
article thumbnail

Galactagogues

RX Note

Dosage in most published studies Domperidone 10 mg 3 times daily for 4 to 10 days. Metoclopramide 10 mg 2 or 3 times daily for 7 to 14 days.

Dosage 52
article thumbnail

ACMT Toxicology Visual Pearl: Who Doesn’t Like a Nice Rosé?

ALiEM - Pharm Pearls

[1,2] Severe symptoms such as hypovolemia, shock, metabolic acidosis Persistent and severe GI symptoms Lethargy or toxic appearance Serum iron level greater than 500 mcg/dL What is the dosage of deferoxamine for iron toxicity? [1] McGraw-Hill Education; 2019 Madiwale T, Liebelt E. 1] Initial dosing starts at 5 mg/kg/hr intravenously.

article thumbnail

Novel anti-epileptic drug demonstrates efficacy

European Pharmaceutical Review

XEN1101 [can] be administered at full strength to begin with” According to Dr French, a key benefit of the drug is its dosage capabilities. It ran between January 2019 and September 2021. The medicine takes over a week to break down in the body. XEN1101 trial findings The Phase IIb study included 285 participants with epilepsy.

Dosage 110
article thumbnail

Kyowa Kirin gets approval in Japan for calcimimetics agent Orkedia Tablets 4mg

Pharmaceutical Business Review

Since the launch in May 2018, its low dosage forms, Orkedia Tablets 1mg and Orkedia Tablets 2mg have helped many patients in the country, stated the company. The higher dose form, Orkedia Tablets 4mg is expected to reduce the burden of medication for patients and lead to an improvement in the satisfaction of treatment.

Dosage 52